Maintenance TS-1 for advanced non-small cell lung cancer: a phase 2 study
Not Applicable
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000003676
- Lead Sponsor
- ational Cancer Center Research Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Not provided
Exclusion Criteria
1) active multiple malignancy 2) infection, ileus, vomiting 3) history of hemoptysis 4) history of thrombotic or hemorrhagic disorders 5) tumor invasion to major thoracic vessel 6) tumor cavitation 7) nonhealing bone fracture 8) uncontrolled digestive ulcer 9) uncontrolled hypertension 10) interstitial pneumonia 11) pregnancy or lactation 12) symptomatic brain metastasis 13) severe drug allergy 3)-6) was excluded only in patients who received bevacizumab-containing first-line chemotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method